These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Analysis by age and sex of efficacy data from placebo-controlled trials of desvenlafaxine in outpatients with major depressive disorder. Kornstein SG, Clayton AH, Soares CN, Padmanabhan SK, Guico-Pabia CJ. J Clin Psychopharmacol; 2010 Jun; 30(3):294-9. PubMed ID: 20473066 [Abstract] [Full Text] [Related]
8. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials. Nelson JC. Depress Anxiety; 2010 Jun; 27(1):12-8. PubMed ID: 20013987 [Abstract] [Full Text] [Related]
11. Tridimensional personality questionnaire factors in major depressive disorder: relationship to anxiety disorder comorbidity and age of onset. Ongur D, Farabaugh A, Iosifescu DV, Perlis R, Fava M. Psychother Psychosom; 2005 Jun; 74(3):173-8. PubMed ID: 15832068 [Abstract] [Full Text] [Related]
13. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder. Alpert JE, Franznick DA, Hollander SB, Fava M. J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591 [Abstract] [Full Text] [Related]
14. The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients. Farabaugh A, Mischoulon D, Fava M, Wu SL, Mascarini A, Tossani E, Alpert JE. Int Clin Psychopharmacol; 2005 Mar; 20(2):87-91. PubMed ID: 15729083 [Abstract] [Full Text] [Related]
15. The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment. Saveanu R, Etkin A, Duchemin AM, Goldstein-Piekarski A, Gyurak A, Debattista C, Schatzberg AF, Sood S, Day CV, Palmer DM, Rekshan WR, Gordon E, Rush AJ, Williams LM. J Psychiatr Res; 2015 Feb; 61():1-12. PubMed ID: 25586212 [Abstract] [Full Text] [Related]
19. Early improvements in anxiety, depression, and anger/hostility symptoms and response to antidepressant treatment. Farabaugh A, Sonawalla S, Johnson DP, Witte J, Papakostas GI, Goodness T, Clain A, Baer L, Mischoulon D, Fava M, Harley R. Ann Clin Psychiatry; 2010 Aug; 22(3):166-71. PubMed ID: 20680189 [Abstract] [Full Text] [Related]
20. Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study. Thase ME, Gelenberg A, Kornstein SG, Kocsis JH, Trivedi MH, Ninan P, Li T, Pedersen R, Keller M. J Psychiatr Res; 2011 Mar; 45(3):412-20. PubMed ID: 20801464 [Abstract] [Full Text] [Related] Page: [Next] [New Search]